Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) (PROMISSE)

The PROMISSE Study is a prospective observational study that will follow 700 pregnant patients who will be grouped and analyzed according to the presence or absence of aPL antibodies and preexisting SLE. The data obtained will be analyzed and used to explore mechanisms and predictors of poor fetal outcome.

To Learn More Contact
Marta M. Guerra, MS 212-774-7361 orĀ guerram@hss.edu
Elianna Kaplowitz, AB at 212-774-7614 or kaplowitze@hss.edu
ClinicalTrials.gov identifier: NCT00198068

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up